Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ebastine for symptom relief in irritable bowel syndrome
NL-OMON55611Phase 2Active, not recruiting
- Sponsor
- UZ Leuven
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in irritable bowel syndrome (IBS) comparing Ebastine with Placebo (2 arms). Primary endpoints: Abdominal pain and Global relief of symptoms. Started Dec 2015; status: active, not recruiting.
02
Drugs
eribulin
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NL-OMON55611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55611.